Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 11:08 PM
Study NCT ID:
NCT00269867
Status:
COMPLETED
Last Update Posted:
2014-11-04
First Post:
2005-12-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis
Sponsor:
Centocor, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR006259
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None